De Wals P - Search Results

1

Spina bifida before and after folic acid fortification in Canada.

De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Uh SH, Zimmer P, Sibbald B, Fernandez B, Lee NS, Niyonsenga T. De Wals P, et al. Birth Defects Res A Clin Mol Teratol. 2008 Sep;82(9):622-6. doi: 10.1002/bdra.20485. Birth Defects Res A Clin Mol Teratol. 2008. PMID: 18655127

2

Trend in prevalence of neural tube defects in Quebec.

De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. De Wals P, et al. Birth Defects Res A Clin Mol Teratol. 2003 Nov;67(11):919-23. doi: 10.1002/bdra.10124. Birth Defects Res A Clin Mol Teratol. 2003. PMID: 14745929

3

Reduction in neural-tube defects after folic acid fortification in Canada.

De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T. De Wals P, et al. N Engl J Med. 2007 Jul 12;357(2):135-42. doi: 10.1056/NEJMoa067103. N Engl J Med. 2007. PMID: 17625125 Free article.

4

Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in Canada.

De Wals P, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Tairou F, Uh SH, Sibbald B, Zimmer P, Fernandez B, Lee NS, Niyonsenga T. De Wals P, et al. Birth Defects Res A Clin Mol Teratol. 2008 Feb;82(2):106-9. doi: 10.1002/bdra.20418. Birth Defects Res A Clin Mol Teratol. 2008. PMID: 18050337

5

Pregnancy planning and folic acid supplement use: results from a survey in Quebec.

Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D, Tremblay C. Morin P, et al. Among authors: de wals p. Prev Med. 2002 Aug;35(2):143-9. doi: 10.1006/pmed.2002.1041. Prev Med. 2002. PMID: 12200099

6

Validity of death and stillbirth certificates and hospital discharge summaries for the identification of neural tube defects in Quebec City.

Tairou F, De Wals P, Bastide A. Tairou F, et al. Among authors: de wals p. Chronic Dis Can. 2006;27(3):120-4. Chronic Dis Can. 2006. PMID: 17306063 Free article.

7

Pregnancy planning: a determinant of folic acid supplements use for the primary prevention of neural tube defects.

Morin P, De Wals P, St-Cyr-Tribble D, Niyonsenga T, Payette H. Morin P, et al. Among authors: de wals p. Can J Public Health. 2002 Jul-Aug;93(4):259-63. doi: 10.1007/BF03405012. Can J Public Health. 2002. PMID: 12154526 Free PMC article.

8

Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.

De Wals P, De Serres G, Niyonsenga T. De Wals P, et al. Among authors: de serres g. JAMA. 2001 Jan 10;285(2):177-81. doi: 10.1001/jama.285.2.177. JAMA. 2001. PMID: 11176810

9

A method for the follow-up of clusters of adverse reproductive outcomes.

Niyonsenga T, De Wals P. Niyonsenga T, et al. Among authors: de wals p. Eur J Epidemiol. 1999 Oct;15(9):833-7. doi: 10.1023/a:1007517830120. Eur J Epidemiol. 1999. PMID: 10608363

10

Biopsychosocial determinants of pregnancy length and fetal growth.

St-Laurent J, De Wals P, Moutquin JM, Niyonsenga T, Noiseux M, Czernis L. St-Laurent J, et al. Among authors: de wals p. Paediatr Perinat Epidemiol. 2008 May;22(3):240-8. doi: 10.1111/j.1365-3016.2008.00926.x. Paediatr Perinat Epidemiol. 2008. PMID: 18426519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters